33 related articles for article (PubMed ID: 31669575)
1. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.
Zheng Q; Lin Z; Xu J; Lu Y; Meng Q; Wang C; Yang Y; Xin X; Li X; Pu H; Gui X; Li T; Xiong W; Lu D
Cell Death Dis; 2018 Feb; 9(3):253. PubMed ID: 29449541
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation.
Chen TJ; Wang HJ; Liu JS; Cheng HH; Hsu SC; Wu MC; Lu CH; Wu YF; Wu JW; Liu YY; Kung HJ; Wang WC
Commun Biol; 2019; 2():105. PubMed ID: 30911680
[TBL] [Abstract][Full Text] [Related]
3. FA-SAT ncRNA interacts with PKM2 protein: depletion of this complex induces a switch from cell proliferation to apoptosis.
Ferreira D; Escudeiro A; Adega F; Anjo SI; Manadas B; Chaves R
Cell Mol Life Sci; 2020 Apr; 77(7):1371-1386. PubMed ID: 31346634
[TBL] [Abstract][Full Text] [Related]
4. RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation.
Zhou S; Obianom ON; Huang J; Guo D; Yang H; Li Q; Shu Y
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376227
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway.
Xu Q; Wu N; Li X; Guo C; Li C; Jiang B; Wang H; Shi D
Cell Death Dis; 2019 Nov; 10(12):874. PubMed ID: 31745071
[TBL] [Abstract][Full Text] [Related]
6. PKM2 promotes cell metastasis and inhibits autophagy via the JAK/STAT3 pathway in hepatocellular carcinoma.
Yu Z; Wang D; Tang Y
Mol Cell Biochem; 2021 May; 476(5):2001-2010. PubMed ID: 33512635
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic Tumor-Derived Exosomes Induce M2 Macrophage Polarization via PKM2/AMPK to Promote Lung Cancer Progression.
Zhou S; Lan Y; Li Y; Li Z; Pu J; Wei L
Cell Transplant; 2022; 31():9636897221106998. PubMed ID: 35818293
[TBL] [Abstract][Full Text] [Related]
8. PKM2 induces mitophagy through the AMPK-mTOR pathway promoting CSFV proliferation.
Liu X; Yan Q; Liu X; Wei W; Zou L; Zhao F; Zeng S; Yi L; Ding H; Zhao M; Chen J; Fan S
J Virol; 2024 Mar; 98(3):e0175123. PubMed ID: 38319105
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment.
Bao L; Xu T; Lu X; Huang P; Pan Z; Ge M
Front Oncol; 2021; 11():773028. PubMed ID: 34926283
[TBL] [Abstract][Full Text] [Related]
10. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
[TBL] [Abstract][Full Text] [Related]
11. Human Periodontal Ligament Stem Cell-Derived Exosomes Promote Bone Regeneration by Altering MicroRNA Profiles.
Liu T; Hu W; Zou X; Xu J; He S; Chang L; Li X; Yin Y; Tian M; Li Z; Zhou J; Jiang X; Chen S
Stem Cells Int; 2020; 2020():8852307. PubMed ID: 33293963
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
[TBL] [Abstract][Full Text] [Related]
13. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression.
Amin S; Yang P; Li Z
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):331-341. PubMed ID: 30826427
[TBL] [Abstract][Full Text] [Related]
15. PKM2 contributes to cancer metabolism.
Wong N; Ojo D; Yan J; Tang D
Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
[TBL] [Abstract][Full Text] [Related]
16. Activation of AMPK promotes thyroid cancer cell migration through its interaction with PKM2 and β-catenin.
Chen J; Zhou Q; Feng J; Zheng W; Du J; Meng X; Wang Y; Wang J
Life Sci; 2019 Dec; 239():116877. PubMed ID: 31669575
[TBL] [Abstract][Full Text] [Related]
17. Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2.
Liu M; Zhang Z; Wang H; Chen X; Jin C
Int J Biol Sci; 2019; 15(3):617-627. PubMed ID: 30745848
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
